Healthcare Analytical Testing Services Market: Growth, Size, Share, and Trends
Healthcare Analytical Testing Services Market by Testing Type (Cell-based, Bioanalytical, Raw Material, Microbial, Stability, Batch-release, Genomic, Method Development & Validation), End User (Pharma, MedTech, Hospital), Region - Global Forecast to 2030
USD 12.46 BN
MARKET SIZE, 2030
CAGR 10.8%
(2025-2030)
435
REPORT PAGES
445
MARKET TABLES
OVERVIEW
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The analytical testing services market is projected to reach USD 12.46 billion by 2030 from USD 7.48 billion in 2025, with a CAGR of 10.8% during the forecast period. The global healthcare analytical testing services market is experiencing strong growth as pharmaceutical, biopharmaceutical, and medical device companies increasingly rely on outsourcing analytical capabilities to ensure product quality, regulatory compliance, and faster time-to-market. The market offers a wide range of services, including bioanalytical testing, method development & validation, stability testing, raw material testing, and microbiological analysis. The growing complexity of biologics and biosimilars, stricter regulatory requirements, and expanding R&D pipelines are driving the demand for specialized analytical partners. Service providers are quickly adopting digital platforms, automation, and AI-based analytics to improve throughput and data reliability throughout the product lifecycle — from discovery to post-market surveillance.
KEY TAKEAWAYS
- The North America healthcare analytical testing market accounted for a 44.1% revenue share in 2024.
- By type, the genomic testing services segment is expected to register the highest CAGR of 11.6%.
- By end user, the biopharmaceutical companies segment is projected to grow at the fastest rate of 11.4% from 2025 to 2030.
- Company Thermo Fisher Scientific Inc. (US), Charles River Laboratories (US), and SGS S.A. (Switzerland) were identified as some of the star players in the healthcare analytical testing services market (global), given their strong market share and product footprint.
- Companies Syneos Health(US), Parexel International (MA) Corporation(US), LGC Limited(UK), Celerion(US), Alcami Corporation(US), Samsung Biologics(Korea), and Curia Global, Inc.(US), among others, have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas, underscoring their potential as emerging market leaders
The healthcare analytical testing services market is rapidly growing, driven by stringent regulatory requirements, the increasing complexity of drug and medical device development, and the rising trend of outsourcing specialized testing services by pharmaceutical and biotechnology companies. A major shift is underway toward platform-based analytical ecosystems integrating LIMS, AI-enabled image analytics, and predictive modeling for faster data interpretation. There is a rising emphasis on method lifecycle management (MLCM), data integrity assurance, and multi-omics analytical testing to support precision medicine and personalized therapies. The demand for stability and extractables/leachables testing is intensifying in biologics and combination products. Additionally, outsourced analytical testing models are evolving from transactional testing to long-term strategic partnerships focusing on continuous process verification and QbD (Quality by Design) frameworks.
TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS
Clients—from multi-specialty hospitals and cancer centers to biopharmaceutical manufacturing facilities—are increasingly impacted by artificial intelligence-powered diagnostics, predictive analytics, and multi-center early detection initiatives. As healthcare delivery approaches the patient directly, telemedicine, portable and point-of-care imaging, and AI-enabled screening platforms are revolutionizing the collection and analysis of clinical data. This fusion of clinical care and analytical services facilitates the development of preventive and precision healthcare models, while concurrently necessitating new compliance and data-sharing protocols throughout the ecosystem.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
MARKET DYNAMICS
Drivers
Impact
Level
Level
-
Increasing outsourcing of analytical testing by pharmaceutical & medical device companies
RESTRAINTS
Impact
Level
Level
-
Increasing pressure on market players due to rising costs and market competition
OPPORTUNITIES
Impact
Level
Level
-
Adoption of new techniques and technologies
CHALLENGES
Impact
Level
Level
-
Shortage of skilled professionals
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Driver: Increasing outsourcing of analytical testing by pharmaceutical & medical device companies
Key growth drivers include increased R&D spending on biologics and biosimilars, rising regulatory focus on analytical validation and data integrity, growing adoption of outsourcing by small and mid-sized pharmaceutical companies, and the emergence of AI-integrated testing processes. Additionally, the movement toward personalized medicine and the rising demand for stability and bioanalytical testing of complex molecules are fueling market growth.
Restraint: Increasing pressure on market players due to rising costs and market competition
High capital and operational costs associated with advanced analytical instrumentation, lack of skilled analytical scientists, and fragmented regulatory expectations across geographies pose key barriers. Moreover, maintaining data integrity across decentralized digital testing platforms remains a persistent challenge.
Opportunity: Adoption of new techniques and technologies
Significant opportunities exist in AI-enabled analytical testing, predictive stability modeling, and digital twin-based quality control systems. Integrating cloud-based LIMS and blockchain-secured data exchange is expected to redefine transparency and compliance in outsourced testing models. Expanding biologics manufacturing in Asia and the increasing focus on biosafety and sterility testing continue to open new service revenue streams.
Challenge: Cost optimization and regulatory compliance harmony
Key challenges include balancing cost optimization with regulatory rigor, ensuring real-time data sharing with clients, and managing global supply chain disruptions for critical analytical reagents. Additionally, harmonizing analytical standards across regulatory bodies such as FDA, EMA, and PMDA remains complex.
Healthcare Analytical Testing Services Market: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
Provides analytical testing for pharmaceuticals, food, and environmental samples | Ensures regulatory compliance, high testing accuracy, and faster time-to-market for products |
 |
Analytical testing for chemicals, consumer goods, and industrial materials | Improved product safety, quality assurance, and risk mitigation |
 |
Testing and certification services across pharmaceuticals, cosmetics, and electronics | Enhances product reliability, market acceptance, and global compliance |
 |
Analytical testing in environmental, food, and chemical sectors | Reduces regulatory risk, ensures sustainability compliance, and supports product innovation |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET ECOSYSTEM
The healthcare analytical testing ecosystem includes contract testing organizations (CTOs), pharmaceutical and biopharma companies, medical device OEMs, CROs, regulatory agencies, and digital health providers. Collaboration is growing across the entire spectrum—from early screening programs and preventive care analytics at healthcare facilities to AI-powered imaging and precision diagnostics in ambulatory and multi-specialty hospitals. Analytical partners are more frequently integrated within clients’ product development and manufacturing systems, supporting comprehensive quality oversight and outcome-focused testing models.
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET SEGMENTS
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Healthcare Analytical Testing Services Market, By Type
Bioanalytical testing services hold the largest market share due to their critical role in drug development and regulatory approval for biologics and biosimilars. These services ensure the quantification and validation of complex biomolecules using advanced LC-MS and immunoassay platforms. Increasing R&D in novel modalities such as gene and cell therapy further boosts demand in this segment.
Healthcare Analytical Testing Services Market, By End User
Pharmaceutical and biopharmaceutical companies dominate the end user landscape as they increasingly outsource analytical functions to ensure faster turnaround and compliance readiness. The surge in new molecule development, biosimilar pipelines, and GMP-compliant analytical documentation drives strong engagement with specialized testing providers.
REGION
North America to be largest region in global analytical testing services market during forecast period
North America leads the market due to its strong regulatory framework, high concentration of pharmaceutical R&D facilities, and established network of analytical service providers. The region’s rapid adoption of digital laboratory infrastructure and data-driven quality management accelerates the uptake of outsourcing.
Healthcare Analytical Testing Services Market: COMPANY EVALUATION MATRIX
The competitive landscape features key players such as Eurofins Scientific, SGS SA, Charles River Laboratories, WuXi AppTec, Intertek Group, PPD (Thermo Fisher Scientific), and Labcorp. Market leaders are differentiating through digital lab automation, AI-driven data analytics, regulatory expertise, and global lab network integration. Emerging players are focusing on niche capabilities like elemental impurity testing, microbiome analysis, and biosafety validation to gain competitive advantage. In the analytical testing services market matrix, Eurofins (Star) leads with a strong market share and extensive service footprint, driven by its advanced testing methodologies and high-precision analytical capabilities widely adopted across pharmaceuticals, food & beverage, and environmental monitoring. SGS (Emerging Leader) is gaining visibility with its specialized testing solutions and tailored services for chemicals and industrial materials, strengthening its position through innovation and niche commercial offerings. While Eurofins dominates through scale and a diversified portfolio, SGS shows significant potential to move toward the leaders’ quadrant as demand for comprehensive, high-accuracy analytical services continues to rise.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
KEY MARKET PLAYERS
MARKET SCOPE
| REPORT METRIC | DETAILS |
|---|---|
| Market Size in 2024 (Value) | USD 7.12 Billion |
| Market Forecast in 2030 (value) | USD 12.46 Billion |
| Growth Rate | 10.8% |
| Years Considered | 2023-2030 |
| Base Year | 2024 |
| Forecast Period | 2025-2030 |
| Units Considered | Value (USD Million/Billion) |
| Report Coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments Covered |
|
| Regions Covered | North America, Asia Pacific, Europe, Middle East & Africa, and Latin America |
WHAT IS IN IT FOR YOU: Healthcare Analytical Testing Services Market REPORT CONTENT GUIDE
DELIVERED CUSTOMIZATIONS
We have successfully delivered the following deep-dive customizations:
| CLIENT REQUEST | CUSTOMIZATION DELIVERED | VALUE ADDS |
|---|---|---|
| Leading OEM |
|
|
| Software provider |
|
|
RECENT DEVELOPMENTS
- February 2024 : Charles River Laboratories (US) partnered with Wheeler Bio, Inc. (US). This agreement accelerated the transition from preclinical to early clinical stages for biotech firms, streamlining processes and providing comprehensive solutions.
- May 2023 : Laboratory Corporation of America Holdings (US) collaborated with Forge Biologics (US) to advance gene therapy development and manufacturing. This collaboration aimed to expedite clinical timelines, overcome analytical development barriers, and address regulatory hurdles associated with manufacturing and development processes.
- May 2023 : SGS S.A. (Switzerland), SGS SA acquired a majority stake in Nutrasource Pharmaceutical and Nutraceutical Services Inc.(Canada). Initially acquiring 60% of Nutrasource's shares, SGS also has the option to acquire the remaining 40% in 2026. This strategic acquisition strengthens SGS's presence in key market segments and enhances its ability to deliver comprehensive services to clients worldwide.
Table of Contents
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
TITLE
PAGE NO
1
INTRODUCTION
38
2
RESEARCH METHODOLOGY
44
3
EXECUTIVE SUMMARY
61
4
PREMIUM INSIGHTS
66
5
MARKET OVERVIEW
Pharmaceutical market thrives on innovation amid regulatory challenges and rising analytical testing demand.
70
5.1
INTRODUCTION
5.2
MARKET DYNAMICS
5.2.1
DRIVERS
5.2.1.1
STRINGENT REGULATORY GUIDELINES
5.2.1.2
GROWING FOCUS ON ANALYTICAL TESTING OF BIOLOGICS & BIOSIMILARS
5.2.1.3
INCREASING OUTSOURCING OF ANALYTICAL TESTING SERVICES BY PHARMACEUTICAL & MEDICAL DEVICE COMPANIES
5.2.1.4
RISING NUMBER OF CLINICAL TRIALS
5.2.1.5
GROWING R&D EXPENDITURE IN PHARMACEUTICAL & BIOPHARMACEUTICAL INDUSTRY
5.2.1.6
RISING ACCEPTANCE OF QUALITY-BY-DESIGN APPROACH IN PHARMACEUTICAL RESEARCH & MANUFACTURING
5.2.2
RESTRAINTS
5.2.2.1
INCREASING PRESSURE ON MARKET PLAYERS DUE TO RISING COSTS AND MARKET COMPETITION
5.2.3
OPPORTUNITIES
5.2.3.1
ADOPTION OF NEW TECHNIQUES AND TECHNOLOGIES
5.2.3.2
GROWING FOCUS ON EMERGING ECONOMIES
5.2.4
CHALLENGES
5.2.4.1
SHORTAGE OF SKILLED PROFESSIONALS
5.2.4.2
SPECIFIC REQUIREMENTS FOR INNOVATIVE FORMULATIONS AND MEDICAL DEVICES
5.2.4.3
CHALLENGES ASSOCIATED WITH ENSURING BIOANALYTICAL TESTING SENSITIVITY
5.3
ECOSYSTEM ANALYSIS
5.4
REGULATORY SCENARIO
5.4.1
REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS
5.4.2
REGULATORY TRENDS
5.4.3
NORTH AMERICA
5.4.4
EUROPE
5.4.5
ASIA PACIFIC
5.5
VALUE CHAIN ANALYSIS
5.5.1
SAMPLE MANAGEMENT & PREPARATION
5.5.2
ANALYTICAL TESTING PROCEDURES
5.5.3
DATA ANALYTICS & INTEGRATION
5.5.4
QUALITY ASSURANCE & CONTROL
5.5.5
CLIENT COMMUNICATION & SERVICE DELIVERY
5.6
CASE STUDY ANALYSIS
5.6.1
CASE STUDY 1: UNLOCKING POTENTIAL OF BIOPHARMACEUTICAL DEVELOPMENT THROUGH ANALYTICAL TESTING OUTSOURCING
5.6.2
CASE STUDY 2: REVOLUTIONIZING PHARMACEUTICAL TESTING
5.7
PORTER’S FIVE FORCES ANALYSIS
5.7.1
THREAT OF NEW ENTRANTS
5.7.2
BARGAINING POWER OF SUPPLIERS
5.7.3
INTENSITY OF COMPETITIVE RIVALRY
5.7.4
BARGAINING POWER OF BUYERS
5.7.5
THREAT OF SUBSTITUTES
5.8
KEY STAKEHOLDERS & BUYING CRITERIA
5.8.1
KEY STAKEHOLDERS IN BUYING PROCESS
5.8.2
KEY BUYING CRITERIA
5.9
TECHNOLOGY ANALYSIS
5.9.1
KEY TECHNOLOGIES
5.9.1.1
CHROMATOGRAPHY
5.9.1.2
MASS SPECTROMETRY (MS)
5.9.1.3
SPECTROSCOPY
5.9.2
COMPLEMENTARY TECHNOLOGIES
5.9.2.1
LABORATORY INFORMATION MANAGEMENT SYSTEMS (LIMS)
5.9.2.2
AUTOMATION & ROBOTICS
5.9.2.3
AI/ML IN DATA ANALYTICS
5.9.3
ADJACENT TECHNOLOGIES
5.9.3.1
SINGLE-USE BIOREACTORS
5.9.3.2
MRNA TECHNOLOGY
5.9.3.3
NEXT-GENERATION SEQUENCING (NGS)
5.10
KEY CONFERENCES & EVENTS, 2024-2025
5.11
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.12
INVESTMENT & FUNDING SCENARIO
5.13
UNMET NEEDS/END-USER EXPECTATIONS
5.14
IMPACT OF AI/GENERATIVE AI ON HEALTHCARE ANALYTICAL TESTING SERVICES MARKET
5.15
TRUMP TARIFF IMPACT ON HEALTHCARE ANALYTICAL TESTING MARKET
5.15.1
INTRODUCTION
5.15.2
KEY TARIFF RATES
5.15.3
PRICE IMPACT ANALYSIS
5.15.4
KEY IMPACT ON VARIOUS REGIONS
5.15.4.1
NORTH AMERICA
5.15.4.2
EUROPE
5.15.4.3
ASIA PACIFIC
6
HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 66 Data Tables
109
6.1
INTRODUCTION
6.2
BIOANALYTICAL TESTING SERVICES
6.2.1
PHARMACOKINETIC & TOXICOKINETIC TESTING SERVICES
6.2.1.1
ESSENTIAL ROLE IN DRUG INDIVIDUALIZED DOSING AND THERAPEUTIC MONITORING TO DRIVE MARKET
6.2.2
IMMUNOGENICITY & NEUTRALIZING ANTIBODY TESTING SERVICES
6.2.2.1
INCREASING REQUIREMENT FOR DRUG SAFETY APPROVALS TO FUEL UPTAKE
6.2.3
BIOMARKER TESTING SERVICES SERVICES
6.2.3.1
GROWING PREFERENCE FOR PERSONALIZED MEDICINE TO FUEL MARKET
6.2.4
BIOASSAY TESTING SERVICES
6.2.4.1
GROWING ADOPTION OF HIGH-CONTENT SCREENING FOR CYTOTOXICITY TESTING TO BOOST DEMAND
6.2.5
OTHER BIOANALYTICAL TESTING SERVICES
6.3
PHYSICAL CHARACTERIZATION SERVICES
6.3.1
LASER PARTICLE SIZE ANALYSIS SERVICES
6.3.1.1
GROWING IMPORTANCE OF PHARMACEUTICAL DOSAGE MANUFACTURING TO DRIVE MARKET
6.3.2
THERMAL ANALYSIS SERVICES
6.3.2.1
ADVANCEMENTS IN THERMAL ANALYSIS TECHNIQUES TO SUPPORT MARKET GROWTH
6.3.3
OPTICAL CHARACTERIZATION SERVICES
6.3.3.1
INCREASING COMPLEXITIES OF BIOLOGICAL STRUCTURES TO BOOST DEMAND
6.3.4
SURFACE AREA ANALYSIS SERVICES
6.3.4.1
GROWING FOCUS ON STREAMLINING DRUG DEVELOPMENT PROCESSES TO FUEL UPTAKE
6.3.5
OTHER PHYSICAL CHARACTERIZATION SERVICES
6.4
METHOD DEVELOPMENT & VALIDATION SERVICES
6.4.1
EXTRACTABLES/LEACHABLES METHOD DEVELOPMENT & VALIDATION SERVICES
6.4.1.1
ADOPTION OF PARENTERALLY ADMINISTERED DRUGS AND BIOLOGICS PRODUCTS TO DRIVE MARKET
6.4.2
PROCESS IMPURITY METHOD DEVELOPMENT & VALIDATION SERVICES
6.4.2.1
INCREASING EMPHASIS ON IMPURITY TESTING TO BOOST MARKET
6.4.3
STABILITY-INDICATING METHOD VALIDATION SERVICES
6.4.3.1
GROWING NEED TO ENSURE SAFETY & EFFICACY OF DRUGS TO DRIVE MARKET
6.4.4
CLEANING VALIDATION & METHOD DEVELOPMENT SERVICES
6.4.4.1
FOCUS ON CONTAMINATION REDUCTION TO FUEL MARKET
6.4.5
ANALYTICAL STANDARD CHARACTERIZATION SERVICES
6.4.5.1
ASSESSMENT OF QUANTITATIVE & QUALITATIVE ACCURACY TO FUEL UPTAKE
6.4.6
TECHNICAL CONSULTING SERVICES
6.4.6.1
STRINGENT REGULATORY COMPLIANCE TO BOOST DEMAND
6.4.7
OTHER METHOD DEVELOPMENT & VALIDATION SERVICES
6.5
RAW MATERIAL TESTING SERVICES
6.5.1
COMPLETE COMPENDIAL TESTING SERVICES
6.5.1.1
NEED TO DETERMINE EFFICACY & SAFETY OF THERAPEUTIC PRODUCTS TO DRIVE MARKET
6.5.2
CONTAINER TESTING SERVICES
6.5.2.1
OPTIMIZATION OF SEALING & EVALUATION OF TEMPERATURE IMPACT TO FUEL UPTAKE
6.5.3
HEAVY METAL TESTING SERVICES
6.5.3.1
UPTAKE OF SPECIALIZED EQUIPMENT TO SUPPORT MARKET GROWTH
6.5.4
WATER CONTENT ANALYSIS SERVICES
6.5.4.1
ADEQUATE MOISTURE CONTENT ANALYSIS TO FUEL MARKET
6.5.5
OTHER RAW MATERIAL TESTING SERVICES
6.6
BATCH-RELEASE TESTING SERVICES
6.6.1
DISSOLUTION TESTING SERVICES
6.6.1.1
WIDE USAGE ACROSS FORMULATION DEVELOPMENT & MANUFACTURING APPLICATIONS TO DRIVE MARKET
6.6.2
ELEMENTAL IMPURITY TESTING SERVICES
6.6.2.1
RISING NEED TO MINIMIZE COST OF IN-HOUSE ANALYSIS TO FUEL MARKET
6.6.3
DISINTEGRATION TESTING SERVICES
6.6.3.1
ABILITY TO ENSURE BATCH-TO-BATCH CONSISTENCY OF PHARMACEUTICAL DOSAGE FORMS TO FUEL MARKET
6.6.4
HARDNESS TESTING SERVICES
6.6.4.1
MEASUREMENT OF TABLET QUALITY TO SUPPORT MARKET GROWTH
6.6.5
FRIABILITY TESTING SERVICES
6.6.5.1
RESISTANCE MEASUREMENT OF TABLETS & GRANULES TO FUEL MARKET
6.6.6
OTHER BATCH-RELEASE TESTING SERVICES
6.7
STABILITY TESTING SERVICES
6.7.1
DRUG SUBSTANCE STABILITY TESTING SERVICES
6.7.1.1
EVIDENCE TESTING ON QUALITY OF PHARMACEUTICAL STABILITY TO FUEL MARKET
6.7.2
FORMULATION EVALUATION STABILITY TESTING SERVICES
6.7.2.1
ANALYSIS OF SHELF LIFE TO FUEL ADOPTION
6.7.3
ACCELERATED STABILITY TESTING SERVICES
6.7.3.1
HIGH STRESS CONDITIONS TO PROVIDE ENHANCED RESULTS
6.7.4
PHOTOSTABILITY TESTING SERVICES
6.7.4.1
SYSTEMIC APPROACH FOR ICH GUIDELINE ADHERENCE TO PROPEL MARKET
6.7.5
FORCED DEGRADATION TESTING SERVICES
6.7.5.1
RISING NEED FOR COMPREHENSIVE STABILITY TESTING TO DRIVE MARKET
6.7.6
OTHER STABILITY TESTING SERVICES
6.8
MICROBIAL TESTING SERVICES
6.8.1
MICROBIAL LIMIT TESTING SERVICES
6.8.1.1
MICROBIAL QUALITY EFFICACY TESTING TO BOOST DEMAND
6.8.2
VIROLOGY TESTING SERVICES
6.8.2.1
INCREASING OUTBREAKS OF VIRAL DISEASES TO DRIVE MARKET
6.8.3
STERILITY TESTING SERVICES
6.8.3.1
RISING DEVELOPMENT OF PARENTERAL PREPARATIONS AND IMMUNOLOGICAL PRODUCTS TO DRIVE MARKET
6.8.4
ENDOTOXIN TESTING SERVICES
6.8.4.1
ENDOXIN-FREE TESTING TO FUEL MARKET
6.8.5
PRESERVATIVE EFFICACY TESTING SERVICES
6.8.5.1
PET TESTING FOR TOXICITY TO FUEL UPTAKE
6.8.6
OTHER MICROBIAL TESTING SERVICES
6.9
ENVIRONMENTAL MONITORING SERVICES
6.9.1
AIR TESTING SERVICES
6.9.1.1
AIR CONTAMINATION TESTING FOR QUALITY CHECKS TO FUEL MARKET
6.9.2
WASTEWATER/ETP TESTING SERVICES
6.9.2.1
NEED TO MINIMIZE WATER CONTAMINATION TO FUEL MARKET
6.9.3
OTHER ENVIRONMENTAL MONITORING TESTING SERVICES
6.10
GENOMIC TESTING SERVICES
6.10.1
DETECTION OF DISEASE MECHANISMS AND TREATMENT RESPONSES TO PROPEL MARKET
6.11
OTHER ANALYTICAL TESTING SERVICES
7
HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 8 Data Tables
164
7.1
INTRODUCTION
7.2
PHARMACEUTICAL COMPANIES
7.2.1
GROWTH IN PHARMACEUTICAL INDUSTRY TO PROPEL MARKET
7.3
BIOPHARMACEUTICAL COMPANIES
7.3.1
INCREASING R&D INVESTMENTS TO FUEL MARKET
7.4
MEDICAL DEVICE COMPANIES
7.4.1
STRINGENT PRODUCT COMMERCIALIZATION GUIDELINES TO DRIVE MARKET
7.5
HOSPITALS & CLINICS
7.5.1
INCREASING INCIDENCE OF CHRONIC DISEASES TO BOOST DEMAND
7.6
FORENSIC LABS
7.6.1
RISING UTILIZATION OF ANALYTICAL TESTING TO FUEL MARKET
7.7
COSMETIC & NUTRACEUTICAL COMPANIES
7.7.1
RISING FOCUS ON QUALITY CONTROL TESTING TO FUEL UPTAKE
7.8
OTHER END USERS
8
HEALTHCARE ANALYTICAL TESTING MARKET, BY REGION
Comprehensive coverage of 8 Regions with country-level deep-dive of 14 Countries | 241 Data Tables.
174
8.1
INTRODUCTION
8.2
NORTH AMERICA
8.2.1
MACROECONOMIC OUTLOOK FOR NORTH AMERICA
8.2.2
US
8.2.2.1
HIGH NUMBER OF PRE-REGISTRATION DRUGS IN PIPELINE TO DRIVE MARKET
8.2.3
CANADA
8.2.3.1
PRESENCE OF WELL-ESTABLISHED CROS TO SUPPORT MARKET GROWTH
8.3
EUROPE
8.3.1
MACROECONOMIC OUTLOOK FOR EUROPE
8.3.2
GERMANY
8.3.2.1
GOVERNMENT SUPPORT AND FLEXIBLE LABOR LAWS TO BOOST DEMAND
8.3.3
FRANCE
8.3.3.1
FAVORABLE GOVERNMENT REGULATIONS TO DRIVE MARKET
8.3.4
UK
8.3.4.1
INCREASING OUTSOURCING OF BIOPHARMACEUTICAL R&D TO DRIVE MARKET
8.3.5
ITALY
8.3.5.1
AVAILABILITY OF DRUG DISCOVERY FUNDING INVESTMENTS TO FUEL MARKET
8.3.6
SWITZERLAND
8.3.6.1
HIGH PRODUCTION OF PHARMA DRUGS TO FUEL UPTAKE
8.3.7
SPAIN
8.3.7.1
RISING NUMBER OF CLINICAL TRIALS TO BOOST DEMAND
8.3.8
REST OF EUROPE
8.4
ASIA PACIFIC
8.4.1
MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
8.4.2
JAPAN
8.4.2.1
EXPANDING GERIATRIC POPULATION AND INCREASING INCIDENCE OF CHRONIC DISEASES TO PROPEL MARKET
8.4.3
CHINA
8.4.3.1
INCREASING INCIDENCE OF INFECTIOUS DISEASES TO BOOST DEMAND
8.4.4
INDIA
8.4.4.1
GROWING FOCUS ON ESTABLISHMENT OF GENOMIC TESTING CENTERS TO DRIVE MARKET
8.4.5
AUSTRALIA
8.4.5.1
LARGE NUMBER OF RESEARCH INSTITUTES TO SUPPORT MARKET UPTAKE
8.4.6
SOUTH KOREA
8.4.6.1
LAUNCH OF INNOVATIVE PHARMA DRUGS TO BOOST DEMAND
8.4.7
REST OF ASIA PACIFIC
8.5
LATIN AMERICA
8.5.1
MACROECONOMIC OUTLOOK FOR LATIN AMERICA
8.5.2
BRAZIL
8.5.2.1
RISING ADOPTION OF EMERGING MEDICAL TECHNOLOGIES TO DRIVE MARKET
8.5.3
MEXICO
8.5.3.1
FAVORABLE REGULATORY ENVIRONMENT FOR API PRODUCTS TO FUEL MARKET
8.5.4
REST OF LATIN AMERICA
8.6
MIDDLE EAST & AFRICA
8.6.1
MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
8.6.2
GCC COUNTRIES
8.6.2.1
IMPROVEMENTS IN HEALTHCARE INFRASTRUCTURE TO BOOST DEMAND
8.6.3
REST OF MIDDLE EAST & AFRICA
9
COMPETITIVE LANDSCAPE
Discover strategic moves and market positions of leading and emerging healthcare analytics players.
310
9.1
OVERVIEW
9.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
9.2.1
OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET
9.3
REVENUE ANALYSIS, 2020−2024
9.4
MARKET SHARE ANALYSIS, 2024
9.5
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
9.5.1
STARS
9.5.2
EMERGING LEADERS
9.5.3
PERVASIVE PLAYERS
9.5.4
PARTICIPANTS
9.5.5
COMPANY FOOTPRINT: KEY PLAYERS, 2024
9.5.5.1
COMPANY FOOTPRINT
9.5.5.2
REGION FOOTPRINT
9.5.5.3
TYPE FOOTPRINT
9.5.5.4
END-USER FOOTPRINT
9.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
9.6.1
PROGRESSIVE COMPANIES
9.6.2
RESPONSIVE COMPANIES
9.6.3
DYNAMIC COMPANIES
9.6.4
STARTING BLOCKS
9.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
9.6.5.1
DETAILED LIST OF STARTUPS/SMES
9.6.5.2
COMPETITIVE BENCHMARKING OF EMERGING PLAYERS/STARTUPS
9.7
COMPANY VALUATION & FINANCIAL METRICS
9.7.1
FINANCIAL METRICS
9.7.2
COMPANY VALUATION
9.8
BRAND/SERVICE COMPARISON
9.8.1
BRAND/SERVICE COMPARATIVE ANALYSIS
9.9
COMPETITIVE SCENARIO
9.9.1
SERVICE LAUNCHES
9.9.2
DEALS
9.9.3
EXPANSIONS
10
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
333
10.1
KEY PLAYERS
10.1.1
EUROFINS SCIENTIFIC SE
10.1.1.1
BUSINESS OVERVIEW
10.1.1.2
SERVICES OFFERED
10.1.1.3
RECENT DEVELOPMENTS
10.1.1.4
MNM VIEW
10.1.2
LABCORP HOLDINGS INC.
10.1.3
INTERTEK GROUP PLC
10.1.4
ICON PLC
10.1.5
IQVIA INC.
10.1.6
WUXI APPTEC CO., LTD.
10.1.7
CHARLES RIVER LABORATORIES
10.1.8
SGS SA
10.1.9
THERMO FISHER SCIENTIFIC INC.
10.1.10
MEDPACE HOLDINGS, INC.
10.1.11
SARTORIUS AG
10.1.12
MERCK KGAA
10.1.13
SOURCE BIOSCIENCE (SUBSIDIARY OF SOURCEBIO INTERNATIONAL PLC)
10.1.14
ALS
10.1.15
FRONTAGE LABORATORIES, INC.
10.1.16
STERIS PLC
10.1.17
ELEMENT MATERIALS TECHNOLOGY
10.1.18
PACE ANALYTICAL SERVICES
10.1.19
ALMAC GROUP
10.1.20
PHARMARON BEIJING CO., LTD.
10.2
OTHER PLAYERS
10.2.1
SYNEOS HEALTH
10.2.2
PAREXEL INTERNATIONAL (MA) CORPORATION
10.2.3
LGC LIMITED
10.2.4
CELERION
10.2.5
BIOAGILYTIX
10.2.6
ALCAMI CORPORATION
10.2.7
SAMSUNG BIOLOGICS
10.2.8
CURIA GLOBAL, INC.
10.2.9
BA SCIENCES
10.2.10
AVANCE BIOSCIENCES
11
APPENDIX
427
11.1
DISCUSSION GUIDE
11.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
11.3
CUSTOMIZATION OPTIONS
11.4
RELATED REPORTS
11.5
AUTHOR DETAILS
LIST OF TABLES
TABLE 1
INCLUSIONS & EXCLUSIONS
TABLE 2
HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: RISK ASSESSMENT ANALYSIS
TABLE 3
PATENT EXPIRY OF BEST-SELLING BIOLOGICS
TABLE 4
IMPACT ANALYSIS: DRIVERS
TABLE 5
IMPACT ANALYSIS: RESTRAINTS
TABLE 6
IMPACT ANALYSIS: OPPORTUNITIES
TABLE 7
IMPACT ANALYSIS: CHALLENGES
TABLE 8
HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: ROLE IN ECOSYSTEM
TABLE 9
NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 10
EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 11
ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 12
LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 13
MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 14
ICH QUALITY GUIDELINES FOR PHARMACEUTICAL GMPS
TABLE 15
OVERVIEW OF GUIDELINES OF LABORATORY SERVICES
TABLE 16
DEVELOPMENT OF GLP ACROSS COUNTRIES
TABLE 17
REGULATORY AUTHORITIES AND LAUNCH OF GLP MONITORING PROGRAMS IN EUROPEAN COUNTRIES
TABLE 18
HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 19
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS
TABLE 20
KEY BUYING CRITERIA FOR HEALTHCARE ANALYTICAL TESTING SERVICES, BY RANK
TABLE 21
HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: DETAILED LIST OF LEADING CONFERENCES & EVENTS
TABLE 22
HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: CURRENT UNMET NEEDS/END-USER EXPECTATIONS
TABLE 23
US-ADJUSTED RECIPROCAL TARIFF RATES
TABLE 24
HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 25
BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 26
BIOANALYTICAL TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 27
PHARMACOKINETIC & TOXICOKINETIC TESTING SERVICES MARKET, BY REGION
TABLE 28
IMMUNOGENICITY & NEUTRALIZING ANTIBODY TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 29
BIOMARKER TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 30
BIOASSAY TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 31
OTHER BIOANALYTICAL TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 32
PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 33
PHYSICAL CHARACTERIZATION SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 34
LASER PARTICLE SIZE ANALYSIS SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 35
THERMAL ANALYSIS SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 36
OPTICAL CHARACTERIZATION SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 37
SURFACE AREA ANALYSIS SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 38
OTHER PHYSICAL CHARACTERIZATION SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 39
METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 40
METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 41
EXTRACTABLES/LEACHABLES METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 42
PROCESS IMPURITY METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 43
STABILITY-INDICATING METHOD VALIDATION SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 44
CLEANING VALIDATION & METHOD DEVELOPMENT SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 45
ANALYTICAL STANDARD CHARACTERIZATION SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 46
TECHNICAL CONSULTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 47
OTHER METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 48
RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 49
RAW MATERIAL TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 50
COMPLETE COMPENDIAL TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 51
CONTAINER TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 52
HEAVY METAL TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 53
WATER CONTENT ANALYSIS SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 54
OTHER RAW MATERIAL TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 55
BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 56
BATCH-RELEASE TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 57
DISSOLUTION TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 58
ELEMENTAL IMPURITY TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 59
BREAKDOWN OF DISINTEGRATION METHODS & IMMERSION MEDIA
TABLE 60
DISINTEGRATION TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 61
HARDNESS TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 62
FRIABILITY TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 63
OTHER BATCH-RELEASE TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 64
STABILITY TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 65
STABILITY TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 66
DRUG SUBSTANCE STABILITY TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 67
FORMULATION EVALUATION STABILITY TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 68
ACCELERATED STABILITY TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 69
PHOTOSTABILITY TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 70
FORCED DEGRADATION TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 71
OTHER STABILITY TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 72
MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 73
MICROBIAL TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 74
STANDARD LIMITS FOR MICROBIAL LIMIT TESTING
TABLE 75
MICROBIAL LIMIT TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 76
VIROLOGY TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 77
STERILITY TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 78
ENDOTOXIN TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 79
PRESERVATIVE EFFICACY TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 80
OTHER MICROBIAL TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 81
ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 82
ENVIRONMENTAL MONITORING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 83
PURITY CLASSES FOR PARTICLES, WATER, AND OIL IN COMPRESSED AIR
TABLE 84
AIR TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 85
STANDARDS FOR WASTEWATER QUALITY
TABLE 86
WASTEWATER/ETP SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 87
OTHER ENVIRONMENTAL MONITORING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 88
GENOMIC TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 89
OTHER ANALYTICAL TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 90
HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 91
HEALTHCARE ANALYTICAL TESTING SERVICES MARKET FOR PHARMACEUTICAL COMPANIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 92
HEALTHCARE ANALYTICAL TESTING SERVICES MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 93
HEALTHCARE ANALYTICAL TESTING SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 94
HEALTHCARE ANALYTICAL TESTING SERVICES MARKET FOR HOSPITALS & CLINICS, BY REGION, 2023–2030 (USD MILLION)
TABLE 95
HEALTHCARE ANALYTICAL TESTING SERVICES MARKET FOR FORENSIC LABS, BY REGION, 2023–2030 (USD MILLION)
TABLE 96
HEALTHCARE ANALYTICAL TESTING SERVICES MARKET FOR COSMETIC & NUTRACEUTICAL COMPANIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 97
HEALTHCARE ANALYTICAL TESTING SERVICES MARKET FOR OTHER END USERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 98
HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 99
NORTH AMERICA: KEY MACROINDICATORS
TABLE 100
NORTH AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 101
NORTH AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 102
NORTH AMERICA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 103
NORTH AMERICA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 104
NORTH AMERICA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 105
NORTH AMERICA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 106
NORTH AMERICA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 107
NORTH AMERICA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 108
NORTH AMERICA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 109
NORTH AMERICA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 110
NORTH AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 111
US: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 112
US: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 113
US: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 114
US: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 115
US: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 116
US: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 117
US: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 118
US: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 119
US: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 120
CANADA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 121
CANADA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 122
CANADA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 123
CANADA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 124
CANADA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 125
CANADA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 126
CANADA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 127
CANADA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 128
CANADA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 129
EUROPE: KEY MACROINDICATORS
TABLE 130
EUROPE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 131
EUROPE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 132
EUROPE: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 133
EUROPE: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 134
EUROPE: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 135
EUROPE: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 136
EUROPE: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 137
EUROPE: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 138
EUROPE: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 139
EUROPE: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 140
EUROPE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 141
GERMANY: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 142
GERMANY: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 143
GERMANY: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 144
GERMANY: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 145
GERMANY: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 146
GERMANY: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 147
GERMANY: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 148
GERMANY: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 149
GERMANY: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 150
FRANCE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 151
FRANCE: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 152
FRANCE: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 153
FRANCE: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 154
FRANCE: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 155
FRANCE: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 156
FRANCE: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 157
FRANCE: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 158
FRANCE: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 159
UK: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 160
UK: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 161
UK: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 162
UK: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 163
UK: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 164
UK: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 165
UK: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 166
UK: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 167
UK: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 168
ITALY: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 169
ITALY: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 170
ITALY: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 171
ITALY: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 172
ITALY: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 173
ITALY: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 174
ITALY: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 175
ITALY: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 176
ITALY: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 177
SWITZERLAND: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 178
SWITZERLAND: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 179
SWITZERLAND: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 180
SWITZERLAND: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 181
SWITZERLAND: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 182
SWITZERLAND: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 183
SWITZERLAND: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 184
SWITZERLAND: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 185
SWITZERLAND: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 186
SPAIN: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 187
SPAIN: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 188
SPAIN: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 189
SPAIN: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 190
SPAIN: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 191
SPAIN: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 192
SPAIN: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 193
SPAIN: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 194
SPAIN: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 195
REST OF EUROPE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 196
REST OF EUROPE: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 197
REST OF EUROPE: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 198
REST OF EUROPE: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 199
REST OF EUROPE: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 200
REST OF EUROPE: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 201
REST OF EUROPE: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 202
REST OF EUROPE: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 203
REST OF EUR0PE: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 204
ASIA PACIFIC: MACROECONOMIC INDICATORS
TABLE 205
ASIA PACIFIC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 206
ASIA PACIFIC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 207
ASIA PACIFIC: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 208
ASIA PACIFIC: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 209
ASIA PACIFIC: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 210
ASIA PACIFIC: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 211
ASIA PACIFIC: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 212
ASIA PACIFIC: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 213
ASIA PACIFIC: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 214
ASIA PACIFIC: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 215
ASIA PACIFIC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 216
JAPAN: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 217
JAPAN: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 218
JAPAN: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 219
JAPAN: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 220
JAPAN: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 221
JAPAN: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 222
JAPAN: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 223
JAPAN: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 224
JAPAN: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 225
CHINA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 226
CHINA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 227
CHINA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 228
CHINA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 229
CHINA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 230
CHINA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 231
CHINA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 232
CHINA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 233
CHINA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 234
INDIA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 235
INDIA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 236
INDIA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 237
INDIA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 238
INDIA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 239
INDIA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 240
INDIA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 241
INDIA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 242
INDIA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 243
AUSTRALIA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 244
AUSTRALIA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 245
AUSTRALIA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 246
AUSTRALIA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 247
AUSTRALIA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 248
AUSTRALIA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 249
AUSTRALIA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 250
AUSTRALIA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 251
AUSTRALIA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 252
SOUTH KOREA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 253
SOUTH KOREA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 254
SOUTH KOREA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 255
SOUTH KOREA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 256
SOUTH KOREA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 257
SOUTH KOREA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 258
SOUTH KOREA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 259
SOUTH KOREA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 260
SOUTH KOREA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 261
REST OF ASIA PACIFIC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 262
REST OF ASIA PACIFIC: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 263
REST OF ASIA PACIFIC: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 264
REST OF ASIA PACIFIC: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 265
REST OF ASIA PACIFIC: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 266
REST OF ASIA PACIFIC: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 267
REST OF ASIA PACIFIC: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 268
REST OF ASIA PACIFIC: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 269
REST OF ASIA PACIFIC: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 270
LATIN AMERICA: KEY MACROINDICATORS
TABLE 271
LATIN AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 272
LATIN AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 273
LATIN AMERICA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 274
LATIN AMERICA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 275
LATIN AMERICA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 276
LATIN AMERICA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 277
LATIN AMERICA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 278
LATIN AMERICA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 279
LATIN AMERICA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 280
LATIN AMERICA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 281
LATIN AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 282
BRAZIL: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 283
BRAZIL: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 284
BRAZIL: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 285
BRAZIL: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 286
BRAZIL: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 287
BRAZIL: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 288
BRAZIL: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 289
BRAZIL: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 290
BRAZIL: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 291
MEXICO: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 292
MEXICO: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 293
MEXICO: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 294
MEXICO: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 295
MEXICO: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 296
MEXICO: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 297
MEXICO: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 298
MEXICO: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 299
MEXICO: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 300
REST OF LATIN AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 301
REST OF LATIN AMERICA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 302
REST OF LATIN AMERICA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 303
REST OF LATIN AMERICA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 304
REST OF LATIN AMERICA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 305
REST OF LATIN AMERICA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 306
REST OF LATIN AMERICA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 307
REST OF LATIN AMERICA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 308
REST OF LATIN AMERICA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 309
MIDDLE EAST & AFRICA: KEY MACROINDICATORS
TABLE 310
MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 311
MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 312
MIDDLE EAST & AFRICA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 313
MIDDLE EAST & AFRICA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 314
MIDDLE EAST & AFRICA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 315
MIDDLE EAST & AFRICA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 316
MIDDLE EAST & AFRICA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 317
MIDDLE EAST & AFRICA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 318
MIDDLE EAST & AFRICA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 319
MIDDLE EAST & AFRICA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 320
MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 321
GCC COUNTRIES: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 322
GCC COUNTRIES: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 323
GCC COUNTRIES: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 324
GCC COUNTRIES: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 325
GCC COUNTRIES: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 326
GCC COUNTRIES: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 327
GCC COUNTRIES: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 328
GCC COUNTRIES: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 329
GCC COUNTRIES: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 330
REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 331
REST OF MIDDLE EAST & AFRICA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 332
REST OF MIDDLE EAST & AFRICA: BUBIOANAZATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 333
REST OF MIDDLE EAST & AFRICA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 334
REST OF MIDDLE EAST & AFRICA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 335
REST OF MIDDLE EAST & AFRICA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 336
REST OF MIDDLE EAST & AFRICA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 337
REST OF MIDDLE EAST & AFRICA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 338
REST OF MIDDLE EAST & AFRICA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 339
OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET
TABLE 340
HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: DEGREE OF COMPETITION
TABLE 341
HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: REGION FOOTPRINT
TABLE 342
HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: TYPE FOOTPRINT
TABLE 343
HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: END-USER FOOTPRINT
TABLE 344
HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: DETAILED LIST OF STARTUPS/SMES
TABLE 345
HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: COMPETITIVE BENCHMARKING OF EMERGING PLAYERS/STARTUPS
TABLE 346
HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: SERVICE LAUNCHES, JANUARY 2021–MAY 2025
TABLE 347
HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: DEALS, JANUARY 2021– JUNE 2025
TABLE 348
HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: EXPANSIONS, JANUARY 2021– JUNE 2025
TABLE 349
EUROFINS SCIENTIFIC SE: COMPANY OVERVIEW
TABLE 350
EUROFINS SCIENTIFIC SE: SERVICES OFFERED
TABLE 351
EUROFINS SCIENTIFIC SE: DEALS, JANUARY 2021–JUNE 2025
TABLE 352
EUROFINS SCIENTIFIC SE: EXPANSIONS, JANUARY 2021–JUNE 2025
TABLE 353
LABCORP HOLDINGS INC.: COMPANY OVERVIEW
TABLE 354
LABCORP HOLDINGS INC.: SERVICES OFFERED
TABLE 355
LABCORP HOLDINGS INC.: SERVICE LAUNCHES, JANUARY 2021–JUNE 2025
TABLE 356
LABCORP HOLDINGS INC.: DEALS, JANUARY 2021–JUNE 2025
TABLE 357
LABCORP HOLDINGS INC.: EXPANSIONS, JANUARY 2021–JUNE 2025
TABLE 358
INTERTEK GROUP PLC: COMPANY OVERVIEW
TABLE 359
INTERTEK GROUP PLC: SERVICES OFFERED
TABLE 360
INTERTEK GROUP PLC: DEALS, JANUARY 2021–JUNE 2025
TABLE 361
INTERTEK GROUP PLC: EXPANSIONS, JANUARY 2021–JUNE 2025
TABLE 362
ICON PLC: COMPANY OVERVIEW
TABLE 363
ICON PLC: SERVICES OFFERED
TABLE 364
ICON PLC: DEALS, JANUARY 2021–JUNE 2025
TABLE 365
IQVIA INC.: COMPANY OVERVIEW
TABLE 366
IQVIA HOLDINGS INC.: SERVICES OFFERED
TABLE 367
IQVIA INC.: EXPANSIONS, JANUARY 2021–JUNE 2025
TABLE 368
IQVIA INC.: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2025
TABLE 369
WUXI APPTEC CO., LTD.: COMPANY OVERVIEW
TABLE 370
WUXI APPTEC CO., LTD.: SERVICES OFFERED
TABLE 371
WUXI APPTEC CO., LTD.: SERVICE LAUNCHES, JANUARY 2021–JUNE 2025
TABLE 372
WUXI APPTEC CO., LTD.: DEALS, JANUARY 2021–JUNE 2025
TABLE 373
WUXI APPTEC CO., LTD.: EXPANSIONS, JANUARY 2021–JUNE 2025
TABLE 374
CHARLES RIVER LABORATORIES: COMPANY OVERVIEW
TABLE 375
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: SERVICES OFFERED
TABLE 376
CHARLES RIVER LABORATORIES: SERVICE LAUNCHES & APPROVALS, JANUARY 2021–JUNE 2025
TABLE 377
CHARLES RIVER LABORATORIES: DEALS, JANUARY 2021–JUNE 2025
TABLE 378
CHARLES RIVER LABORATORIES: EXPANSIONS, JANUARY 2021–JUNE 2025
TABLE 379
SGS SA: COMPANY OVERVIEW
TABLE 380
SGS SA: SERVICES OFFERED
TABLE 381
SGS SA: SERVICE LAUNCHES, JANUARY 2021–JUNE 2025
TABLE 382
SGS SA: DEALS, JANUARY 2021–JUNE 2025
TABLE 383
SGS SA: EXPANSIONS, JANUARY 2021–JUNE 2025
TABLE 384
SGS SA: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2025
TABLE 385
THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
TABLE 386
THERMO FISHER SCIENTIFIC INC.: SERVICES OFFERED
TABLE 387
THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021–JUNE 2025
TABLE 388
THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2021–JUNE 2025
TABLE 389
MEDPACE HOLDINGS, INC.: COMPANY OVERVIEW
TABLE 390
MEDPACE HOLDINGS, INC.: SERVICES OFFERED
TABLE 391
MEDPACE HOLDINGS, INC.: DEALS, JANUARY 2021–JUNE 2025
TABLE 392
MEDPACE HOLDINGS, INC.: EXPANSIONS, JANUARY 2021–JUNE 2025
TABLE 393
SARTORIUS AG: COMPANY OVERVIEW
TABLE 394
SARTORIUS AG: SERVICES OFFERED
TABLE 395
SARTORIUS AG: DEALS, JANUARY 2021–JUNE 2025
TABLE 396
SARTORIUS AG: EXPANSIONS, JANUARY 2021–JUNE 2025
TABLE 397
MERCK KGAA: COMPANY OVERVIEW
TABLE 398
MERCK KGAA: SERVICES OFFERED
TABLE 399
MERCK KGAA: SERVICE LAUNCHES, JANUARY 2021–JUNE 2025
TABLE 400
MERCK KGAA: DEALS, JANUARY 2021–JUNE 2025
TABLE 401
MERCK KGAA: EXPANSIONS, JANUARY 2021–JUNE 2025
TABLE 402
MERCK KGAA: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2025
TABLE 403
SOURCEBIO INTERNATIONAL PLC: COMPANY OVERVIEW
TABLE 404
SOURCEBIO INTERNATIONAL PLC: SERVICES OFFERED
TABLE 405
SOURCEBIO INTERNATIONAL PLC: SERVICE LAUNCHES, JANUARY 2021–JUNE 2025
TABLE 406
SOURCEBIO INTERNATIONAL PLC: EXPANSIONS, JANUARY 2021–JUNE 2025
TABLE 407
ALS: COMPANY OVERVIEW
TABLE 408
ALS: SERVICES OFFERED
TABLE 409
ALS: DEALS, JANUARY 2021–JUNE 2025
TABLE 410
FRONTAGE LABORATORIES, INC.: COMPANY OVERVIEW
TABLE 411
FRONTAGE LABORATORIES, INC.: SERVICES OFFERED
TABLE 412
FRONTAGE LABORATORIES, INC.: DEALS, JANUARY 2021–JUNE 2025
TABLE 413
FRONTAGE LABORATORIES, INC.: EXPANSIONS, JANUARY 2021–JUNE 2025
TABLE 414
STERIS: COMPANY OVERVIEW
TABLE 415
STERIS PLC: SERVICES OFFERED
TABLE 416
STERIS PLC: SERVICE LAUNCHES, JANUARY 2021–JUNE 2025
TABLE 417
STERIS PLC: EXPANSIONS, JANUARY 2021–JUNE 2025
TABLE 418
STERIS PLC: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2025
TABLE 419
ELEMENT MATERIALS TECHNOLOGY: COMPANY OVERVIEW
TABLE 420
ELEMENT MATERIALS TECHNOLOGY: SERVICES OFFERED
TABLE 421
ELEMENT MATERIALS TECHNOLOGY: SERVICE LAUNCHES, JANUARY 2021–JUNE 2025
TABLE 422
ELEMENT MATERIALS TECHNOLOGY: DEALS, JANUARY 2021–JUNE 2025
TABLE 423
ELEMENT MATERIALS TECHNOLOGY: EXPANSIONS, JANUARY 2021–JUNE 2025
TABLE 424
ELEMENT MATERIALS TECHNOLOGY: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2025
TABLE 425
PACE ANALYTICAL SERVICES: COMPANY OVERVIEW
TABLE 426
PACE ANALYTICAL SERVICES: SERVICES OFFERED
TABLE 427
PACE ANALYTICAL SERVICES: DEALS, JANUARY 2021–JUNE 2025
TABLE 428
PACE ANALYTICAL SERVICES: EXPANSIONS, JANUARY 2021–JUNE 2025
TABLE 429
ALMAC GROUP: COMPANY OVERVIEW
TABLE 430
ALMAC GROUP: SERVICES OFFERED
TABLE 431
ALMAC GROUP: SERVICE APPROVALS, JANUARY 2021–JUNE 2025
TABLE 432
ALMAC GROUP: DEALS, JANUARY 2021–JUNE 2025
TABLE 433
ALMAC GROUP: EXPANSIONS, JANUARY 2021–JUNE 2025
TABLE 434
PHARMARON BEIJING CO., LTD.: COMPANY OVERVIEW
TABLE 435
PHARMARON BEIJING CO., LTD.: SERVICES OFFERED
TABLE 436
PHARMARON BEIJING CO., LTD.: DEALS, JANUARY 2021–JUNE 2025
TABLE 437
SYNEOS HEALTH: COMPANY OVERVIEW
TABLE 438
PAREXEL INTERNATIONAL (MA) CORPORATION: COMPANY OVERVIEW
TABLE 439
LGC LIMITED: COMPANY OVERVIEW
TABLE 440
CELERION: COMPANY OVERVIEW
TABLE 441
BIOAGILYTIX: COMPANY OVERVIEW
TABLE 442
ALCAMI CORPORATION: COMPANY OVERVIEW
TABLE 443
SAMSUNG BIOLOGICS: COMPANY OVERVIEW
TABLE 444
CURIA GLOBAL, INC.: COMPANY OVERVIEW
TABLE 445
BA SCIENCES: COMPANY OVERVIEW
TABLE 446
AVANCE BIOSCIENCES: COMPANY OVERVIEW
LIST OF FIGURES
FIGURE 1
MARKET & GEOGRAPHIC SEGMENTATION
FIGURE 2
REGIONAL SEGMENTATION
FIGURE 3
HEALTHCARE ANALYTICAL TESTING MARKET: RESEARCH METHODOLOGY
FIGURE 4
RESEARCH DESIGN
FIGURE 5
BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 6
BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 7
RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
FIGURE 8
MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 9
REVENUE SHARE ANALYSIS: COMPANY ILLUSTRATION
FIGURE 10
TOP-DOWN APPROACH
FIGURE 11
CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 12
HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: CAGR PROJECTIONS, 2025-2030
FIGURE 13
DATA TRIANGULATION METHODOLOGY
FIGURE 14
HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)
FIGURE 15
BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)
FIGURE 16
PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)
FIGURE 17
HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
FIGURE 18
GEOGRAPHIC SNAPSHOT OF HEALTHCARE ANALYTICAL TESTING SERVICES MARKET
FIGURE 19
RISING NUMBER OF CLINICAL TRIALS AND GROWING OUTSOURCING OF PHARMA R&D SERVICES TO CROS TO PROPEL MARKET
FIGURE 20
BIOANALYTICAL TESTING SERVICES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN GERMANY IN 2O24
FIGURE 21
CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
FIGURE 22
NORTH AMERICA REGION TO DOMINATE MARKET DURING FORECAST PERIOD
FIGURE 23
HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 24
INCREASING NUMBER OF CLINICAL TRIALS WORLDWIDE (2004–2024)
FIGURE 25
PERCENTAGE OF REGISTERED STUDIES BY LOCATION (AS OF 2024)
FIGURE 26
PHARMACEUTICAL & BIOPHARMACEUTICAL R&D EXPENDITURE, 2002–2024
FIGURE 27
HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: ECOSYSTEM ANALYSIS
FIGURE 28
HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: VALUE CHAIN ANALYSIS
FIGURE 29
HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 30
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR HEALTHCARE ANALYTICAL TESTING SERVICES
FIGURE 31
KEY BUYING CRITERIA FOR HEALTHCARE ANALYTICAL TESTING SERVICES, BY END USER
FIGURE 32
REVENUE SHIFT IN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET
FIGURE 33
HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: NUMBER OF DEALS, BY KEY PLAYER, 2019–2023 (USD MILLION)
FIGURE 34
HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023 (USD MILLION)
FIGURE 35
VALUE OF INVESTOR DEALS IN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY KEY PLAYER, 2019–2023 (USD MILLION)
FIGURE 36
USE OF GEN AI ON HEALTHCARE ANALYTICAL TESTING SERVICES MARKET
FIGURE 37
NORTH AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET
FIGURE 38
ASIA PACIFIC: HEALTHCARE ANALYTICS TESTING SERVICES MARKET SNAPSHOT
FIGURE 39
REVENUE ANALYSIS OF KEY PLAYERS IN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, 2020−2024
FIGURE 40
MARKET SHARE ANALYSIS OF KEY PLAYERS IN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET (2024)
FIGURE 41
HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
FIGURE 42
HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: COMPANY FOOTPRINT
FIGURE 43
HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
FIGURE 44
EV/EBITDA OF KEY VENDORS
FIGURE 45
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 46
HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: BRAND/SERVICE COMPARATIVE ANALYSIS
FIGURE 47
EUROFINS SCIENTIFIC SE: COMPANY SNAPSHOT (2024)
FIGURE 48
LABCORP HOLDINGS INC.: COMPANY SNAPSHOT (2024)
FIGURE 49
INTERTEK GROUP PLC: COMPANY SNAPSHOT (2024)
FIGURE 50
ICON PLC: COMPANY SNAPSHOT (2024)
FIGURE 51
IQVIA INC.: COMPANY SNAPSHOT (2024)
FIGURE 52
WUXI APPTEC CO., LTD.: COMPANY SNAPSHOT (2024)
FIGURE 53
CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2024)
FIGURE 54
SGS SA: COMPANY SNAPSHOT (2024)
FIGURE 55
THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024)
FIGURE 56
MEDPACE HOLDINGS, INC.: COMPANY SNAPSHOT (2024)
FIGURE 57
SARTORIUS AG: COMPANY SNAPSHOT (2024)
FIGURE 58
MERCK KGAA: COMPANY SNAPSHOT (2024)
FIGURE 59
ALS: COMPANY SNAPSHOT (2024)
FIGURE 60
FRONTAGE LABORATORIES, INC.: COMPANY SNAPSHOT (2024)
FIGURE 61
STERIS PLC: COMPANY SNAPSHOT (2024)
Methodology
This study utilized both primary and secondary sources to analyze the healthcare analytical testing services market. Extensive secondary research was conducted, followed by primary research to validate findings with industry experts. Various methods were used to estimate the overall market size, including top-down and bottom-up approaches. Market segmentation and data triangulation were then applied to define different segments within the market. The research also explored influencing factors, key players, industry trends, competitive dynamics, and strategies of market participants.
Secondary Research
The secondary research process relies on various sources like directories, databases (e.g., Bloomberg Business, Factiva, D&B Hoovers), white papers, annual reports, company documents, investor presentations, and SEC filings. This research was essential for a detailed market analysis of healthcare analytical testing services, providing insights into key players and market segmentation trends. Additionally, it highlighted significant market and technology developments, leading to the creation of a database of industry leaders.
The market for healthcare analytical testing services is assessed using secondary data from various sources. This analysis reviews major companies' product portfolios and performance, providing insights into the industry's value chain, key players, and market segmentation from both market and technology perspectives.
Primary Research
In the primary research process for this report, various supply- and demand-side sources were interviewed to gather qualitative and quantitative data. Supply-side sources included industry experts like CEOs and key executives from prominent companies in healthcare analytical testing services. On the demand side, primary sources comprised OEMs, private testing organizations, and service providers. This research validated market segmentation, identified key players, and gathered insights on industry trends and dynamics.
Following market engineering, which involved calculations for statistics, breakdowns, and forecasting, we conducted extensive primary research to verify critical numbers. We identified market segmentation types, trends, and the competitive landscape while examining key dynamics such as drivers, restraints, opportunities, and challenges faced by major players.
In the comprehensive market engineering process, both top-down and bottom-up approaches were employed to estimate and forecast market segments. Extensive qualitative and quantitative analyses highlighted essential insights presented in the report.
A breakdown of the primary respondents is provided below:
Note 1: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Note 2: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 2 billion, Tier 2 = USD 50 million to USD 2 billion, and Tier 3 = < USD 50 million.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were utilized to estimate and validate the healthcare analytical testing services market size and its segments. Revenue share analysis of leading players helped determine the global market size, with insights gathered from primary and secondary research. This included reviewing annual reports of top players and conducting interviews with key executives. The research methodology used to estimate the market size includes the following:
Data Triangulation
After arriving at the overall market size from the market size estimation process explained above, the global healthcare analytical testing services market was split into segments and subsegments. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides. Additionally, the market was validated using both top-down and bottom-up approaches.
Market Definition
The healthcare industry increasingly relies on healthcare analytical testing services to optimize the intricate processes involved in drug discovery and development and the testing of medical devices. These services play a crucial role for pharmaceutical, biopharmaceutical, and medical device companies by providing comprehensive analytical solutions that ensure the safety, efficacy, and quality of new therapies and devices.
Through advanced techniques such as mass spectrometry, chromatography, and molecular profiling, these analytical services enable the identification of active compounds, the assessment of biological responses, and the evaluation of product reliability. By streamlining workflows and ensuring regulatory compliance, these services accelerate the development timelines and enhance the overall effectiveness of clinical trials, ultimately leading to more successful market introductions and improved patient outcomes.
Stakeholders
- Healthcare Analytical Testing Service Providers
- Pharmaceutical & Biopharmaceutical Companies
- Biotechnology Companies
- Bioanalytical Testing Service Providers
- Environmental Testing Service Providers
- Contract Research Organizations (CROs)
- Medical Device Manufacturing Companies
- Academic Universities
- Research Institutes
- Research Laboratories
- Government Associations
- Cosmetic Companies
- Nutraceutical Companies
- Hospitals and Clinics
- Forensic Laboratories
- Market Research and Consulting Firms
- Venture Capitalists and Investors
Report Objectives
- To define, describe, and forecast the healthcare analytical testing services market based on type, end user, and region
- To provide detailed information regarding the major factors influencing the growth potential of the global healthcare analytical testing services market (drivers, restraints, opportunities, challenges, and trends)
- To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the global healthcare analytical testing services market
- To analyze key growth opportunities in the global healthcare analytical testing services market for key stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of market segments and/or subsegments with respect to five major regions: North America (the US and Canada), Europe (Germany, the UK, France, Italy, Spain, and the Rest of Europe), Asia Pacific (Japan, China, India, Australia, Thailand, Singapore, Indonesia, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of Latin America), and the Middle East & Africa (GCC Countries and the Rest of Middle East & Africa)
- To profile the key players in the global healthcare analytical testing services market and comprehensively analyze their market shares and core competencies
- To track and analyze the competitive developments undertaken in the global healthcare analytical testing services market, such as agreements, expansions, and product launches
Key Questions Addressed by the Report
What is the projected value of the global healthcare analytical testing services market during the forecast period?
The global healthcare analytical testing services market is projected to grow from USD 7.48 billion in 2025 to USD 12.48 billion by 2030, at a CAGR of 10.8% during the forecast period.
By type, which segment accounted for the largest market share in 2024?
Based on type, the bioanalytical testing services segment accounted for the largest share of the healthcare analytical testing services market in 2024. The time constraints and exorbitant costs of drug discovery being controlled through effective bioanalysis are key factors driving market growth.
What strategies are adopted by the leading players in the market?
The leading players in the market have opted for launches, collaborations, partnerships, agreements, and expansions as critical growth strategies to expand their presence in the global healthcare analytical testing services market.
What are the primary factors expected to drive the growth of the healthcare analytical testing services market?
The stringent regulatory guidelines and increasing outsourcing of analytical testing by pharmaceutical & medical device companies are the key factors driving market growth.
What are the specific challenges companies face in the healthcare analytical testing services market?
The presence and adoption of new techniques and technologies such as high-resolution accurate mass spectrometry (HRAM) instruments, morphologically directed Raman spectroscopy (MDRS), and fully validated laboratory information & management systems (LIMS) may challenge this market's growth.
Personalize This Research
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
Let Us Help You
- What are the Known and Unknown Adjacencies Impacting the Healthcare Analytical Testing Services Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Custom Market Research Services
We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements
Get 10% Free Customisation
Before You Go
Expand Beyond Healthcare Analytical Testing Services Market
Explore the top 20 industries influencing your market growth
Human and AI Powered Market Intelligence
Find Untapped Markets
Growth opportunities and latent adjacency in Healthcare Analytical Testing Services Market